Paclitaxel Injection, Powder, Lyophilized, For Suspension
Product Images NDC 75007-041

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 75007-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ningbo Shuangcheng Pharmaceutical Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Paclitaxel 01)

Image Description (Paclitaxel 01)
An instructional illustration showing a vial labeled for lyophilized powder suspension with a needle inserted through its stopper, depicting preparation or reconstitution of an injectable drug product typically used for intravenous administration.*
FDA Label Image

Image Description (Paclitaxel 02)

Image Description (Paclitaxel 02)
Chemical structure diagram of Paclitaxel (albumin-bound), illustrating its molecular framework with aromatic rings, acetyl, and hydroxyl groups.*
FDA Label Image

Image Description (Paclitaxel 03)

Image Description (Paclitaxel 03)
A Kaplan-Meier survival plot comparing the proportion of survival over time (months) for patients treated with Paclitaxel Protein-Bound Particles for Injectable Suspension (albumin-bound) combined with Gemcitabine versus Gemcitabine alone. The graph includes patient numbers at risk at various time points and shows survival trends up to 39 months.*
FDA Label Image

Image Description (Paclitaxel 04)

Image Description (Paclitaxel 04)
Label for Paclitaxel Protein-Bound Particles for Injectable Suspension (albumin-bound) 100 mg per vial. This lyophilized powder for intravenous use is a single-dose vial. The label includes storage instructions and a barcode. It is produced by Ningbo Shuangcheng Pharmaceutical Co., Ltd.*
FDA Label Image

Image Description (Paclitaxel 05)

Image Description (Paclitaxel 05)
Packaging label for Paclitaxel Protein-Bound Particles for Injectable Suspension (albumin-bound) 100 mg per vial. It is a lyophilized powder for injection via intravenous route, labeled for single-dose vial use. The labeler is Ningbo Shuangcheng Pharmaceutical Co., Ltd. The label includes storage instructions, dosage verification, single-dose vial warning, and an NDC number 75007-041-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.